文献速递胸部技术与安全CT

疑似COVID-19患者胸部CT报告的观察者间一致性与临床意义

Observer agreement and clinical significance of chest CT reporting in patients suspected of COVID-19.
PubMed 文献 · Eur Radiol · 2020-08-29

2020年3月16日至24日,241例因疑似COVID-19就诊的患者接受胸部CT和SARS-CoV-2 RT-PCR,8名观察者(2名胸部、2名普通高年资放射科医生、2名低年资放射科医生、2名急诊医生)回顾性将CT分为4类(提示性、兼容COVID-19肺炎、非提示性、正常)。所有读者间分类一致性良好(κ=0.61),共识分类与RT-PCR相关:提示性类别中97% RT-PCR阳性,兼容性50%,非提示性31%,正常11%。

要点

  • CT分类为「提示性」对COVID-19预测价值高,该类别中97%患者RT-PCR阳性。
  • CT分类为「非提示性」时仍有31%患者RT-PCR阳性,不能完全排除COVID-19。
  • 存在基础肺部疾病时观察者间一致性降低且RT-PCR阳性病例较少被分类为「提示性」。

核心结论

  • 在疑似COVID-19患者中,胸部CT按发现分类的报告观察者间一致性良好;在疫情背景下考虑住院的患者中,CT分类为「提示性」高度预测COVID-19,而「兼容性」与「非提示性」之间的预测价值下降。

研究设计与样本

  • 回顾性研究,纳入2020年3月16日至24日连续241例因疑似COVID-19就诊于医院的患者,均行胸部CT和SARS-CoV-2 RT-PCR;8名观察者(2名胸部放射科医生、2名普通高年资放射科医生、2名低年资放射科医生、2名急诊医生)回顾性将每例CT分为4类;采用Kappa系数评估所有读者间及相似经验读者对间的一致性;共识分类结果与RT-PCR correlated。

关键影像表现/征象

  • CT分类为「提示性」的病例中97% RT-PCR阳性。
  • CT分类为「兼容性」的病例中50% RT-PCR阳性。
  • CT分类为「非提示性」的病例中31% RT-PCR阳性。
  • CT分类为「正常」的病例中11% RT-PCR阳性。

诊断标准与关键数值

  • 4类分类标准:提示性(evocative)、兼容COVID-19肺炎(compatible)、非提示性(not evocative)、正常(normal)。
  • 所有读者间4类分类一致性良好,κ=0.61(95%CI 0.60-0.63)。
  • 相似经验读者对间一致性中等至良好,κ=0.54-0.75。
  • 各分类一致性:提示性κ=0.81(95%CI 0.79-0.83,非常好);兼容性κ=0.32(95%CI 0.29-0.34,一般);非提示性κ=0.56(95%CI 0.54-0.58,中等);正常κ=0.58(95%CI 0.56-0.61,中等)。

临床应用与阅片要点

  • 使用4类分类报告胸部CT发现可提供良好观察者间一致性,尤其「提示性」类别一致性非常好。
  • CT分类为「提示性」高度预测COVID-19,但「非提示性」类别中近三分之一患者RT-PCR阳性,解读时需结合RT-PCR。
  • 存在基础肺部疾病时,观察者间一致性降低且RT-PCR阳性病例较少被分类为「提示性」。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To assess interobserver agreement and clinical significance of chest CT reporting in patients suspected of COVID-19.

METHODS: From 16 to 24 March 2020, 241 consecutive patients addressed to hospital for COVID-19 suspicion had both chest CT and SARS-CoV-2 RT-PCR. Eight observers (2 thoracic and 2 general senior radiologists, 2 junior radiologists, and 2 emergency physicians) retrospectively categorized each CT into one out of 4 categories (evocative, compatible for COVID-19 pneumonia, not evocative, and normal). Observer agreement for categorization between all readers and pairs of readers with similar experience was evaluated with the Kappa coefficient. The results of a consensus categorization were correlated to RT-PCR.

RESULTS: Observer agreement across the 4 categories was good between all readers (κ value 0.61 95% CI 0.60-0.63) and moderate to good between pairs of readers (0.54-0.75). It was very good (κ 0.81 95% CI 0.79-0.83), fair (κ 0.32 95% CI 0.29-0.34), moderate (κ 0.56 95% CI 0.54-0.58), and moderate (0.58 95% CI 0.56-0.61) for the categories evocative, compatible, not evocative, and normal, respectively. RT-PCR was positive in 97%, 50%, 31%, and 11% of cases in the respective categories. Observer agreement was lower (p < 0.001) and RT-PCR positive cases less frequently categorized evocative in the presence of an underlying pulmonary disease (p < 0.001).

CONCLUSION: Interobserver agreement for chest CT reporting using categorization of findings is good in patients suspected of COVID-19. Among patients considered for hospitalization in an epidemic context, CT categorized evocative is highly predictive of COVID-19, whereas the predictive value of CT decreases between the categories compatible and not evocative.

KEY POINTS: • In patients suspected of COVID-19, interobserver agreement for chest CT reporting into categories is good, and very good to categorize CT "evocative." • Chest CT can participate in estimating the likelihood of COVID-19 in patients presenting to hospital during the outbreak, CT categorized "evocative" being highly predictive of the disease whereas almost a third of patients with CT "not evocative" had a positive RT-PCR in our study. • Observer agreement is lower and CTs of positive RT-PCR cases less frequently "evocative" in presence of an underlying pulmonary disease.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Debray MP, Tarabay H, Males L, et al. Observer agreement and clinical significance of chest CT reporting in patients suspected of COVID-19. Eur Radiol. 2020. PMID: 32862289. doi:10.1007/s00330-020-07126-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。